Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CLADRIBINE FOR PEAK IDENTIFICATION CRS (10 MG)

CLADRIBINE FOR PEAK IDENTIFICATION CRS (10 MG)

4291-63-8

DISCOVER
CLADRIBINE IMPURITY C CRS (5 MG)

CLADRIBINE IMPURITY C CRS (5 MG)

1839-18-5

DISCOVER
DEMBREXINE HYDROCHLORIDE MONOHYDRATE CRS (10 MG)

DEMBREXINE HYDROCHLORIDE MONOHYDRATE CRS (10 MG)

52702-51-9

DISCOVER
DOPEXAMINE DIHYDROCHLORIDE CRS (10 MG)

DOPEXAMINE DIHYDROCHLORIDE CRS (10 MG)

86484-91-5

DISCOVER
DOPEXAMINE IMPURITY B CRS (10MG)

DOPEXAMINE IMPURITY B CRS (10MG)

NA

DISCOVER
DOPEXAMINE IMPURITY F CRS (10MG)

DOPEXAMINE IMPURITY F CRS (10MG)

NA

DISCOVER
ENALAPRILAT DIHYDRATE CRS (100 MG)

ENALAPRILAT DIHYDRATE CRS (100 MG)

84680-54-6

DISCOVER
TROPISETRON HYDROCHLORIDE CRS(40 MG)

TROPISETRON HYDROCHLORIDE CRS(40 MG)

105826-92-4

DISCOVER
ETHYL INDOLE-3-CARBOXYLATE CRS (15 MG)

ETHYL INDOLE-3-CARBOXYLATE CRS (15 MG)

776-41-0

DISCOVER
TROPISETRON IMPURITY B CRS (10 MG)

TROPISETRON IMPURITY B CRS (10 MG)

771-50-6

DISCOVER
GUAIACOL CRS (1500 MG)

GUAIACOL CRS (1500 MG)

90-05-1

DISCOVER
SODIUM LAURILSULFATE CRS (40 MG)

SODIUM LAURILSULFATE CRS (40 MG)

151-21-3

DISCOVER